The flux of plasma free Trp through TDO and down the KP, in the absence of changes in TDO (or IDO) activity, is an important determinant of production of KP metabolites and is influenced primarily by changes in circulating albumin and NEFA, both of which undergo significant changes in disease states including cancer (see below). The gene discussed is IDO1; the disease is cancer.